A Study Exploring the Use of Vaccine and Antigen Challenges for Immune Monitoring in Healthy Participants
Clinical trial NCT03953196 · COMPLETED
Trial details
- NCT number
- NCT03953196
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-08
- Primary completion
- 2019-12-26
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.